FI57255C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-alkyl-2-nitro-5-vinyl-imidazoler - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-alkyl-2-nitro-5-vinyl-imidazoler Download PDF

Info

Publication number
FI57255C
FI57255C FI1864/72A FI186472A FI57255C FI 57255 C FI57255 C FI 57255C FI 1864/72 A FI1864/72 A FI 1864/72A FI 186472 A FI186472 A FI 186472A FI 57255 C FI57255 C FI 57255C
Authority
FI
Finland
Prior art keywords
nitro
alkyl
vinyl
imidazoler
framework
Prior art date
Application number
FI1864/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI57255B (fi
Inventor
Bruno Cavalleri
Giancarlo Lancini
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of FI57255B publication Critical patent/FI57255B/fi
Publication of FI57255C publication Critical patent/FI57255C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI1864/72A 1971-07-30 1972-06-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-alkyl-2-nitro-5-vinyl-imidazoler FI57255C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4297871 1971-07-30
IT4297871 1971-07-30

Publications (2)

Publication Number Publication Date
FI57255B FI57255B (fi) 1980-03-31
FI57255C true FI57255C (fi) 1980-07-10

Family

ID=11254772

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1864/72A FI57255C (fi) 1971-07-30 1972-06-30 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-alkyl-2-nitro-5-vinyl-imidazoler

Country Status (27)

Country Link
US (1) US3954789A (es)
JP (2) JPS528832B1 (es)
AR (4) AR193999A1 (es)
AT (3) AT316545B (es)
AU (1) AU462723B2 (es)
BE (1) BE785024A (es)
CA (1) CA997340A (es)
CH (4) CH574934A5 (es)
CS (1) CS180585B2 (es)
DD (2) DD99996A5 (es)
DE (2) DE2229223C3 (es)
DK (1) DK154295C (es)
ES (3) ES405343A1 (es)
FI (1) FI57255C (es)
FR (1) FR2148073B1 (es)
GB (1) GB1362444A (es)
HU (2) HU164926B (es)
IE (1) IE36530B1 (es)
IL (1) IL39880A (es)
LU (1) LU65816A1 (es)
NL (2) NL148602B (es)
NO (2) NO135591C (es)
PL (4) PL85190B1 (es)
RO (6) RO63047A (es)
SE (3) SE417711B (es)
SU (4) SU463263A3 (es)
ZA (1) ZA724723B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1480192A (en) * 1975-01-15 1977-07-20 Lepetit Spa 1-methyl-2-nitro-imidazole-5-methanol derivatives
GB1526451A (en) * 1976-01-27 1978-09-27 Lepetit Spa Alpha,alpha,1-trimethyl-2-nitroimidazole-5-methanol derivatives
US4218460A (en) * 1976-09-29 1980-08-19 Basf Aktiengesellschaft Nitroimidazoles
US4199592A (en) * 1978-08-29 1980-04-22 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-2-nitroimidazoles
ZW24982A1 (en) * 1981-11-30 1983-06-15 Hoffmann La Roche 2-nitroimidazoles
JPH10338673A (ja) * 1997-06-04 1998-12-22 Nippon Bayeragrochem Kk イソニコチン酸ヒドラジド誘導体および有害生物防除剤
ZA200507752B (en) 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
WO2007002931A2 (en) 2005-06-29 2007-01-04 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs
WO2008083101A1 (en) 2006-12-26 2008-07-10 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124627C (es) * 1964-08-12
NL143227B (nl) * 1968-11-15 1974-09-16 Lepetit Spa Werkwijze ter bereiding van imidazoolderivaten met bactericide werking.
US3583985A (en) * 1969-04-09 1971-06-08 Richardson Merrell Inc Nitroimidazolyl nitrones
US3711495A (en) * 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles

Also Published As

Publication number Publication date
CA997340A (en) 1976-09-21
JPS5038111B1 (es) 1975-12-06
AT316545B (de) 1974-07-10
AU4422872A (en) 1974-01-10
FR2148073A1 (es) 1973-03-11
NL148602B (nl) 1976-02-16
SE392615B (sv) 1977-04-04
SU581863A3 (ru) 1977-11-25
DK154295B (da) 1988-10-31
PL84350B1 (es) 1976-03-31
RO63047A (fr) 1978-05-15
NL7210339A (es) 1973-02-01
AR193885A1 (es) 1973-05-31
NO135591B (es) 1977-01-17
DE2229248B2 (de) 1979-07-26
ES405341A1 (es) 1975-07-01
US3954789A (en) 1976-05-04
AR199084A1 (es) 1974-08-08
DE2229248C3 (de) 1980-03-27
DD99996A5 (es) 1973-09-05
SU463263A3 (ru) 1975-03-05
SE7503080L (es) 1975-03-18
PL85190B1 (es) 1976-04-30
HU164926B (es) 1974-05-28
LU65816A1 (es) 1972-11-29
SU466684A3 (ru) 1975-04-05
NL7210340A (es) 1973-02-01
AU462723B2 (en) 1975-07-03
CH572040A5 (es) 1976-01-30
IE36530B1 (en) 1976-11-24
AR199680A1 (es) 1974-09-23
RO61517A (es) 1976-12-15
RO63048A (fr) 1978-05-15
CS180585B2 (en) 1978-01-31
DE2229248A1 (de) 1973-02-15
NO135592C (es) 1977-04-27
FI57255B (fi) 1980-03-31
GB1362444A (en) 1974-08-07
IL39880A0 (en) 1972-09-28
DE2229223A1 (de) 1973-02-15
CH580596A5 (es) 1976-10-15
SE417200B (sv) 1981-03-02
AR193999A1 (es) 1973-06-12
DD99995A5 (es) 1973-09-05
AT315164B (de) 1974-05-10
JPS528832B1 (es) 1977-03-11
NO135592B (es) 1977-01-17
ES418921A1 (es) 1976-10-16
BE785024A (fr) 1972-10-16
IE36530L (en) 1973-01-30
PL82980B1 (es) 1975-12-31
DE2229223C3 (de) 1975-12-18
FR2148073B1 (es) 1975-11-28
NL149491B (nl) 1976-05-17
AT323736B (de) 1975-07-25
CH574934A5 (es) 1976-04-30
HU167622B (es) 1975-11-28
SU567404A3 (ru) 1977-07-30
ES405343A1 (es) 1975-07-16
DE2229223B2 (de) 1975-05-07
CH574933A5 (es) 1976-04-30
DK154295C (da) 1989-03-28
IL39880A (en) 1976-04-30
RO63049A (fr) 1978-07-15
ZA724723B (en) 1973-04-25
SE417711B (sv) 1981-04-06
RO63453A (fr) 1978-06-15
RO62787A (es) 1977-08-15
PL87673B1 (es) 1976-07-31
NO135591C (es) 1977-04-27

Similar Documents

Publication Publication Date Title
FI57255C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 1-alkyl-2-nitro-5-vinyl-imidazoler
USRE34960E (en) Carbapenem compounds, and compositions containing them
CA1141383A (en) Quinoline carboxylic acid derivatives
US4337199A (en) Antibiotic β-lactam compounds, production thereof, and their use as antimicrobial agent
Martin et al. Sulfuranes. II. Isolation and characterization of a crystalline dialkoxydiarylsulfurane
Carter et al. LL-F42248α, a novel chlorinated pyrrole antibiotic
Roy et al. Aranorosinol A and aranorosinol B, two new metabolites from Pseudoarachniotus roseus: production, isolation, structure elucidation and biological properties
FI63583B (fi) Azetidinderivat foer anvaendning som mellanfoereningar till frmstaellning av terapeutiskt aktiva 3-desacetoxi-cefalosp aorsyraderivat och foerfarande foer framstaellning av azeti ndierivaten
Reddy et al. Synthesis and anti-microbial activity of new (1-alkyl-1H-1, 2, 3-triazol-4-yl) methyl-2H-chromene-3-carboxylates: A click chemistry approach
Arnoldi et al. Activity of a series of. beta.-lactams against some phytopathogenic fungi
IMUTA et al. Carbapenem and penem antibiotics. VII. Synthesis and antibacterial activity of 1β-methyl-2-(quaternary heteroaromatic-thiomethyl) carbapenems
FI62098B (fi) Foerfarande foer framstaellning av tiazolo(5,4-c)rifamycin sv och dess derivat
Biondi et al. Synthesis and biological activity of novel tricyclic β-lactams
US4426390A (en) Novel β-lactam compounds, process for producing thereof, and use thereof as medicines
US4189569A (en) Seldomycin factor 5 derivatives
US4169834A (en) Rifamycin derivatives
US3185687A (en) 4-nitro-pyridazines
US4387052A (en) Antibiotic PA-39504-X3 and production thereof
Ito et al. ANTIBIOTIC YC 73 OF PSEUDOMONAS ORIGIN. III SYNTHESIS OF THIOFORMIN ANALOGUES
EP0005140B1 (en) Novel 4-desoxy-thiazolo (5,4-c) rifamycin derivatives and a process for preparing them
US4497742A (en) Isomerization of β-lactam compounds
US4647408A (en) Carbapenem-type antibiotics
US4190581A (en) Novel penicillin derivatives
US4978748A (en) Intermediate and process for producing the antibacterial and antitumor agents LL-E33288ε-I and LL-E33288Epsilon-Br
AT375374B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen und von deren salzen